Iovance Biotherapeutics to Present at Upcoming Conferences Page 1

SAN CARLOS, Calif., Sept. 3, 2024 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing and delivering novel polyclonal tumor-infiltrating lymphocyte (“TIL”) therapies for cancer patients, today announced that its senior management plans to present at the following conferences:

• Wells Fargo Healthcare Conference
  Fireside Talk: September 4, 2024 at 3:45pm ET
  Boston, MA
• Baird Global Healthcare Conference
  Fireside Talk: September 10, 2024 at 2:35pm ET
  New York, NY
• HC Wainwright Global Investment Conference
  Presentation: September 11, 2024 at 11:00 a.m. ET
  New York, NY

The live and archived webcasts are available at https://ir.iovance.com/news-events/events-presentations.